D
DFTX
Definium Therapeutics
17.13
-0.14-0.81%After Hours: 16.98 -0.15 -0.90%19:41 02/20 EST
OPEN/PREV CLOSE17.27/17.27
TODAY RANGE16.83-17.72
VOL1.01M
MARKET CAP1.69B
52 WEEK RANGE4.700-18.70
AVG VOL (3M)1.90M
% TURNOVER1.03%
TURNOVER--
P/E (TTM)-8.6871
% RANGE5.15%
EPS(TTM)-1.9719
P/E(FORWARD)-8.5224
P/B10.07
BVPS1.701
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.65B
SHARES OUTSTANDING98.51M
NEXT EARNINGS03/04-03/09
FREE FLOAT96.54M
LOT SIZE1
EX-DATE08/29/2022
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Psychedelic: Exclusive talk with nonprofit organization MAPS
Simply Wall St·2d ago
Jefferies’ DT120 Confidence and Psychedelic Tailwinds Might Change The Case For Investing In Definium Therapeutics (DFTX)
Simply Wall St·02/11 07:27
A Look At Definium Therapeutics (DFTX) Valuation After Roger Adsett Joins The Board
TipRanks·02/05 15:40
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
Simply Wall St·02/05 11:33
Is Adsett’s Board Appointment And Breakthrough DT120 Status Altering The Investment Case For Definium Therapeutics (DFTX)?
Simply Wall St·02/03 13:32
A Look At Definium Therapeutics (DFTX) Valuation After Analyst Coverage And FDA Breakthrough Therapy Designation
Reuters·02/02 22:05
LSD therapy biotech Definium sued for alleged trade secret theft
Reuters·02/02 21:00
Definium Therapeutics Grants Stock Options to New Employees
Simply Wall St·01/31 03:40
Definium Therapeutics Adds Commercial Leader As Phase 3 Milestones Approach
Dow Jones·01/30 20:34
Definium Therapeutics Price Target Announced at $30.00/Share by Jefferies
TipRanks·01/30 14:56
Spotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
Same Industry
Name/Symbol
Change%
Price